| # | Drug | Count |
|---|---|---|
| 0 | VEDOLIZUMAB | 8 |
| 1 | INFLIXIMAB | 7 |
| 2 | PREDNISONE | 7 |
| 3 | ADALIMUMAB | 5 |
| 4 | BUDESONIDE | 4 |
| 5 | METHOTREXATE | 4 |
| 6 | METHOTREXATE SODIUM | 4 |
| 7 | INFLIXIMAB-DYYB | 3 |
| 8 | UPADACITINIB | 3 |
| 9 | ATOVAQUONE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 3 | 0.0009 |
| 1 | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | 2 | 0.0006 |
| 2 | PENICILLIN G | 1 | 0.0004 |
| 3 | ATOVAQUONE | 2 | 0.0002 |
| 4 | VALGANCICLOVIR | 2 | 0.0001 |
| 5 | CLADRIBINE | 1 | 0.0001 |
| 6 | VEDOLIZUMAB | 8 | 0.0001 |
| 7 | PROMETHAZINE HYDROCHLORIDE | 1 | 0.0001 |
| 8 | INSULIN DEGLUDEC | 1 | 0.0000 |
| 9 | UPADACITINIB | 3 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimalarial [EPC] | 2 | 0.0002 |
| 1 | Antiprotozoal [EPC] | 2 | 0.0002 |
| 2 | Integrin Receptor Antagonist [EPC] | 8 | 0.0001 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Purine Antimetabolite [EPC] | 3 | 0.0000 |
| 5 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 2 | 0.0000 |
| 6 | Interleukin-23 Antagonist [EPC] | 2 | 0.0000 |
| 7 | Janus Kinase Inhibitor [EPC] | 3 | 0.0000 |
| 8 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 11 | 0.0000 |